Recent advances in the prevention and treatment of respiratory syncytial virus disease
Journal of General Virology · 09.04.2025 · 106 (4)
DOI: 10.1099/jgv.0.002095 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of General Virology, erschienen am 09.04.2025. Verfasst von Alexandra Sanchez-Martinez und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Vaccines, Antiviral Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is associated with considerable healthcare burden; as such, prevention and treatment of RSV have long been considered a priority. Historic failures in RSV vaccine development had slowed the research field. However, the discovery of the conformational change in the RSV fusion protein (F) has led to considerable advancements in the field. The RSV pharmaceutical landscape has drastically changed in recent years with successful trials of both vaccines and second-generation mAbs leading to licensing and roll-out of these agents in several countries. RSV preventative and therapeutic measures will likely have a significant impact on RSV-related morbidity and mortality. However, there are still gaps in the protection that these immunizations offer that should be addressed. Many unanswered questions about RSV infection dynamics and subsequent disease should be a focus of ongoing research. This review discusses the currently licensed RSV pharmaceuticals and others that have recently progressed to clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
- Medical Radiation Physics Group, The National Physical Laboratory, Teddington, UK.
- School of Mathematics and Physics, Faculty of Engineering and Physical Sciences, University of Surrey, Guildford, UK.
- Immunisations and Vaccine Preventable Disease Division, United Kingdom Health Security Agency, London, UK.
- Department of Paediatric Infectious Diseases, Royal Belfast Hospital for Sick Children, 274 Grosvenor Rd, Belfast, BT12 6BA, UK.
- Acute Paediatric Medical Services, Antrim Area Hospital, Bush Road, Antrim, BT41 2RL, UK.
Zitieren
APA
Sanchez-Martinez, A., Moore, T., Freitas, T. S., Benzaken, T. R., O'Hagan, S., Millar, E., Groves, H. E., Drysdale, S. B., & Broadbent, L. (2025). Recent advances in the prevention and treatment of respiratory syncytial virus disease. Journal of General Virology, 106(4). https://doi.org/10.1099/jgv.0.002095
Vancouver
Sanchez-Martinez A, Moore T, Freitas TS, Benzaken TR, O'Hagan S, Millar E, et al. Recent advances in the prevention and treatment of respiratory syncytial virus disease. Journal of General Virology. 2025;106(4). doi:10.1099/jgv.0.002095
BibTeX
@article{SanchezMartinez2025,
author = {Sanchez-Martinez, Alexandra and Moore, Tom and Freitas, Telma Sancheira and Benzaken, Tami R and O'Hagan, Shaun and Millar, Emma and Groves, Helen E and Drysdale, Simon B and Broadbent, Lindsay},
title = {Recent advances in the prevention and treatment of respiratory syncytial virus disease},
journal = {Journal of General Virology},
year = {2025},
volume = {106},
number = {4},
doi = {10.1099/jgv.0.002095}
}
EUVIMED